Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Ariosa Diagnostics, Inc v. Sequenom, Inc
Case Number:
3:11-cv-06391
Court:
Nature of Suit:
Judge:
Firms
- Arnold & Porter
- Bartko Zankel
- Duane Morris
- Glancy Prongay
- Irell & Manella
- Michelman & Robinson
- Oblon
- Orrick Herrington
- Russ August & Kabat
- Satterlee Stephens
- Turner Boyd
- Weil Gotshal
- Womble Bond
Companies
Sectors & Industries:
-
December 03, 2013
How They Won It: Irell Nixes Patent For Prenatal DNA Test
Irell & Manella LLP attorneys took aggressive steps to strike down a patent covering a prenatal DNA test licensed by Sequenom Inc. by citing a host of case law holding that natural phenomena and their discoveries cannot be patented to net a win for molecular diagnostics firm Ariosa Diagnostics Inc.
-
October 31, 2013
Sequenom Patent For Prenatal DNA Test Invalidated
A California federal judge on Wednesday struck down a patent covering a prenatal DNA test licensed to Sequenom Inc., relying on a slew of decisions by the U.S. Supreme Court holding that naturally occurring phenomena are not patentable, giving a win to accused infringer Ariosa Diagnostics Inc.
-
July 06, 2012
Calif. Judge Won't Halt Sale Of Prenatal Blood Test In IP Row
A federal judge on Thursday allowed Ariosa Diagnostics Inc. to continue selling its noninvasive prenatal Harmony test, dismissing competitor Sequenom Inc.'s motion for a preliminary injunction claiming the product infringes on its patent for a competing test.